JESSICA MACWILLIAMS: Open Payments
NPI 1578663001 · AGAWAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,721 in 168 payments from 19 companies in 2025. Trend: 2023 $4,644 · 2024 $4,104 · 2025 $3,721
Food & beverage: $3,648Education: $74
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $770 |
| UCB, Inc. | 28 | $731 |
| Novartis Pharmaceuticals Corporation | 18 | $410 |
| Lilly USA, LLC | 10 | $228 |
| Incyte Corporation | 8 | $205 |
| E.R. Squibb & Sons, L.L.C. | 9 | $198 |
| Galderma Laboratories, L.P. | 12 | $185 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $167 |
| Janssen Biotech, Inc. | 7 | $165 |
| GENZYME CORPORATION | 4 | $158 |
Products named: Bimzelx, SKYRIZI, RINVOQ, COSENTYX, DUPIXENT, OPZELURA, Sotyktu, TALTZ.
Industry payments across MA — which companies pay providers there.
